These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9489509)

  • 1. The activity of MAO A and B in rat renal cells and tubules.
    Guimarães JT; Soares-da-Silva P
    Life Sci; 1998; 62(8):727-37. PubMed ID: 9489509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual pattern of beta-phenylethylamine deamination in the rat heart.
    Tiago Guimarães J; Soares-da-Silva P
    Neurobiology (Bp); 2000; 8(1):109-18. PubMed ID: 11008882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of MAO-A and MAO-B selective inhibitors Ro 41-1049 and Ro 19-6327 on the deamination of newly formed dopamine in the rat kidney.
    Fernandes MH; Soares-da-Silva P
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1309-13. PubMed ID: 2124622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of monoamine oxidase A and B in the deamination of newly-formed dopamine in the rat kidney.
    Fernandes MH; Soares-da-Silva P
    J Neural Transm Suppl; 1990; 32():155-9. PubMed ID: 2089083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of type A and B monoamine oxidase selective inhibition by Ro 41-1049 and Ro 19-6327 on dopamine outflow in rat kidney slices.
    Pestana M; Soares-da-Silva P
    Br J Pharmacol; 1994 Dec; 113(4):1269-74. PubMed ID: 7889283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deamination of newly-formed dopamine in rat renal tissues.
    Fernandes MH; Pestana M; Soares-da-Silva P
    Br J Pharmacol; 1991 Mar; 102(3):778-82. PubMed ID: 1364853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential substrate specificity of monoamine oxidase in the rat heart and renal cortex.
    Guimarães JT; Vindis C; Soares-da-Silva P; Parini A
    Life Sci; 2003 Jul; 73(8):955-67. PubMed ID: 12818349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
    Bondiolotti GP; Galva MD; Villa F; Sciaba L; Picotti GB
    Biochem Pharmacol; 1995 Jun; 50(1):97-102. PubMed ID: 7605351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo effects of the monoamine oxidase inhibitors Ro 41-1049 and Ro 19-6327 on the production and fate of renal dopamine.
    Vieira-Coelho MA; Fernandes MH; Soares-da-Silva P
    J Neural Transm Suppl; 1994; 41():365-70. PubMed ID: 7931252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type A and B monoamine oxidase activities in the human and rat kidney.
    Fernandes MH; Soares-da-Silva P
    Acta Physiol Scand; 1992 Aug; 145(4):363-7. PubMed ID: 1529723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Types A and B monoamine oxidase contribute to the metabolism of norepinephrine in perfused lungs of rats.
    Westwood NN; Bryan-Lluka LJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):815-21. PubMed ID: 8246156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of selective and reversible MAO inhibitors on dopamine outflow in rat striatum: a microdialysis study.
    Colzi A; d'Agostini F; Kettler R; Borroni E; Da Prada M
    J Neural Transm Suppl; 1990; 32():79-84. PubMed ID: 2089114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opossum kidney (OK) cells in culture synthesize and degrade the natriuretic hormone dopamine: a comparison with rat renal tubular cells.
    Guimarães JT; Vieira-Coelho MA; Serrão MP; Soares-da-Silva P
    Int J Biochem Cell Biol; 1997 Apr; 29(4):681-8. PubMed ID: 9363646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonistic actions of renal dopamine and 5-hydroxytryptamine: effects of amine precursors on the cell inward transfer and decarboxylation.
    Soares-da-Silva P; Pinto-do-O PC
    Br J Pharmacol; 1996 Mar; 117(6):1187-92. PubMed ID: 8882614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of renal dopaminergic system activity during cyclosporine A administration in the rat.
    Pestana M; Vieira-Coelho MA; Pinto-do-O PC; Fernandes MH; Soares-da-Silva P
    Br J Pharmacol; 1995 Aug; 115(8):1349-58. PubMed ID: 8564191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Design and Evaluation of an l-Dopa-Lazabemide Prodrug for the Treatment of Parkinson's Disease.
    Hoon M; Petzer JP; Viljoen F; Petzer A
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential deamination of dopamine by an A type monoamine oxidase in rat brain.
    Waldmeier PC; Delini-Stula A; Maître L
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):9-14. PubMed ID: 934359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.
    Fagervall I; Ross SB
    J Neurochem; 1986 Aug; 47(2):569-76. PubMed ID: 3734795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.